News
5h
Capital Market on MSNSPARC tanks after psoriasis, eczema drug flunks Phase 2 trialsIn a regulatory filing, SPARC said that its partner, Sun Pharmaceutical Industries (SPIL), reported top-line results from ...
Those that know, know: Atopic dermatitis, otherwise known as eczema, is no walk in the park—especially for Black folks. According to the National Eczema Association, African Americans are more likely ...
Find out how E45 moisturiser can easily be integrated into your daily routine for a radiance that shines through every aspect ...
Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2. All three cohorts show separation from placebo ...
The investigational drug demonstrated robust STAT6 degradation in blood and skin that was well tolerated and safe in healthy ...
Investors were surely discovering drug discovery company AbCellera Biologics ( ABCL 6.19%) as the trading week kicked off on ...
Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...
AI can determine eczema severity from images, with results correlating with severity assigned by board-certified clinicians.
A new analysis suggests artificial intelligence algorithms are able to accurately assess lesion severity in patients with ...
Melanie Hilgers, a dermatologist in Luxembourg, treats many sufferers in her practice, in which she often sees a combination ...
The American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis (AD).
Discover a study that found that pure atopic dermatitis patients had a significantly higher prevalence of cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results